1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 30779980 | Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice. | 2019 Apr | 1 |